Martin Sabarsky, JD, MBA
Mr. Sabarsky was promoted to President and CEO of Cellana in April 2011. Prior to this he had been CFO and COO of HRBP since 2008. He has significant leadership experience in the industrial biotechnology industry, as well as extensive transactional experience across multiple industries, including the biotechnology industry, having worked as an investment banker and attorney on over $13 billion of transactions in aggregate. Prior to joining HRBP, from 2000 to 2007, he led the corporate development function at Diversa Corporation and led a number of additional functions within the Finance and Accounting department during his tenure with Diversa, with increasing levels of management responsibility, most recently as Vice President of Corporate Development and a member of the Executive Committee. Before Diversa, Mr. Sabarsky worked from 1999 to 2000 as an investment banker with Bear, Stearns & Co. Inc., where he focused on financings and mergers and acquisitions within the life sciences industry and was a lead banker on Diversa’s $200 million IPO in February 2000. Prior to joining Bear Stearns, from 1995 to 1999, he worked as a transactional attorney with Latham & Watkins LLP, where he focused on the corporate, securities, and tax aspects of financings and mergers and acquisitions for clients in the real estate, healthcare, venture capital, and biotechnology industries, among others. Mr. Sabarsky has an A.B. in Biology and Political Science from Brown University, a J.D. from Harvard Law School, and an M.B.A. from the Rady School of Management at the University of California, San Diego.